• 1. Emulsion soft templating of carbide-derived carbon nanospheres with controllable porosity for capacitive electrochemical energy storage?
  M. Zeiger,N. J?ckel,P. Strubel,L. Borchardt,R. Reinhold,W. Nickel,J. Eckert,V. Presser,S. Kaskel J. Mater. Chem. A, 2015,3, 17983-17990
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 4. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

Introduction to (3-isopropoxypyridin-4-yl)methanamine and Its Significance in Modern Chemical Research

Compound with the CAS number 1502188-63-7, specifically identified as (3-isopropoxypyridin-4-yl)methanamine, represents a fascinating subject of study in the realm of chemical biology and pharmaceutical development. This compound, characterized by its unique structural features, has garnered attention due to its potential applications in various scientific domains. The presence of both pyridine and isopropoxy functional groups in its molecular framework suggests a rich chemical reactivity that could be exploited for the synthesis of novel bioactive molecules.

The pyridine ring, a heterocyclic aromatic structure, is well-documented for its role in numerous pharmacologically active compounds. Its ability to interact with biological targets through hydrogen bonding and hydrophobic interactions makes it a cornerstone in drug design. In contrast, the isopropoxy group introduces a certain level of steric hindrance and electronic modulation, which can significantly influence the compound's overall properties. These structural elements combined suggest that (3-isopropoxypyridin-4-yl)methanamine could exhibit a range of biological activities, making it a promising candidate for further investigation.

Recent advancements in computational chemistry and molecular modeling have enabled researchers to predict the behavior of such compounds with unprecedented accuracy. By leveraging these tools, scientists can simulate the interactions of (3-isopropoxypyridin-4-yl)methanamine with various biological targets, thereby gaining insights into its potential therapeutic applications. Such simulations have been instrumental in identifying novel drug candidates that exhibit high affinity and selectivity for specific biological pathways.

The synthesis of (3-isopropoxypyridin-4-yl)methanamine involves a series of carefully orchestrated chemical reactions that highlight the ingenuity of modern synthetic methodologies. The introduction of the isopropoxy group at the 3-position of the pyridine ring requires precise control over reaction conditions to ensure high yield and purity. Techniques such as nucleophilic substitution and metal-catalyzed cross-coupling reactions have been employed to achieve this transformation efficiently. These synthetic strategies not only demonstrate the versatility of current chemical approaches but also underscore the importance of meticulous planning in drug development.

In addition to its synthetic significance, (3-isopropoxypyridin-4-yl)methanamine has shown promise in preliminary biological assays. Studies have indicated that this compound exhibits inhibitory activity against certain enzymes and receptors, suggesting potential applications in treating various diseases. For instance, its ability to modulate enzyme activity could make it a valuable tool in developing treatments for metabolic disorders or inflammatory conditions. Furthermore, its interaction with specific receptors may open avenues for creating novel therapeutics targeting neurological disorders.

The role of computational tools in understanding the biological activity of (3-isopropoxypyridin-4-yl)methanamine cannot be overstated. Advanced algorithms can predict how this compound might bind to biological targets at the atomic level, providing critical insights into its mechanism of action. These predictions are often validated through experimental studies, leading to a more comprehensive understanding of the compound's properties. Such interdisciplinary approaches are essential for translating laboratory findings into tangible therapeutic benefits.

The future prospects for (3-isopropoxypyridin-4-yl)methanamine are bright, with ongoing research aimed at expanding its applications across multiple domains. Efforts are underway to optimize its synthesis for scalability and cost-effectiveness, ensuring that it remains accessible for further development. Additionally, collaborations between academic institutions and pharmaceutical companies are fostering innovation by combining expertise in chemistry, biology, and medicine. This synergy is crucial for accelerating the discovery and development of new drugs that address unmet medical needs.

In conclusion, compound CAS number 1502188-63-7, known as (3-isopropoxypyridin-4-yl)methanamine, represents a compelling example of how structural innovation can lead to significant advancements in chemical biology and pharmaceuticals. Its unique combination of functional groups offers a rich foundation for further exploration, while recent technological advancements provide powerful tools for understanding its potential applications. As research continues to uncover new possibilities, this compound is poised to play an important role in shaping the future of drug development.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)